QGel Company

QGel is an innovating drug discovery.
Technology: Organoids
Industry: P4 Medicine, Providers/ R&D
Headquarters: Lausanne, Vaud, Switzerland
Founded Date: 2009-01-01
Employees Number: 11-50
Funding Status: Private Equity
Investors Number: 1
Total Funding: 12008592
Estimated Revenue: $1M to $10M
Last Funding Date: 2016-12-12
Last Funding Type: Private Equity

Visit Website
https://twitter.com/QGelBio
Register and Claim Ownership